Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 3 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar mikemicmac (< 20) Submitted: 5/4/2013 11:23:44 AM : Outperform Start Price: $7.62 ARNA Score: -60.61

It seems like Americans are always looking for that pill that takes care of their needs especially when it comes to dieting. The market here is beyond vast and the drug has been approved! If this diet aid is marketed well I believe we are looking at huge amounts of sales. Go Belviq!!

Featured Broker Partners


Advertisement